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physical functioning (PF), general health (GH), vitality (VT) and mental health (MH) 
subscales. Multiple linear regressions were used to assess the association between usage 
patterns, HRQoL scores and other sociodemographic, health behavior and health service 
utilization characteristics. RESULTS: Of 7158 women retained at Survey 4, 885 were 
identiﬁ ed as having diabetes with overall prevalence of cardiovascular medication use 
of 89.9%. After adjusting for other covariates, being on three classes of cardiovascular 
medications was signiﬁ cantly associated with increased scores on PF (coefﬁ cient 16.134, 
95% CI 6.940–25.327), GH (10.058, 95% CI 2.649–17.468) and MH (12.896, 95% 
CI 6.562–15.882) subscales. Being on any two classes was associated with increased 
scores on PF and GH (coefﬁ cient 14.744, 95% CI 5.988–23.501 and 8.334, 95% CI 
1.200–15.467, respectively), whereas using single cardiovascular drug was only signiﬁ -
cantly associated with increased scores on PF (coefﬁ cient 12.346, 95% CI 3.943–
20.750). CONCLUSIONS: Intensive use of cardiovasular medications to support 
diabetes management was shown to be subjectively beneﬁ cial. Concern about perceived 
deterioration on HRQoL attributable to pill burden might be captured if a diabetes-
speciﬁ c instrument was employed. 
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OBJECTIVES: CBIA is a small group discussion which emphasizes on the active role 
of participants in looking for information. CBIA has been proven effective to improve 
tuberculosis patient’s adherence to treatment program, pharmacy assistant’s skills in 
hypertension drug information service, and skills in early detection of Brest cancer. 
Therefore, CBIA was developed adapting the original CBIA, enriched with key mes-
sages in healthy life-style for diabetic patients as CBIA-DM. This study was aimed to 
assess the impact of CBIA-DM on diabetic patients’ quality of life. METHODS: Time 
series, pre and post quasi-experimental design. Three groups were involved in the 
study: CBIA-DM, DM-club and normal-care group. Data were collected in pre-
intervention, immediately, one, three and 6 months post intervention using WHO-
QOL-bref questionnaires Bahasa version. Categorizing scores in good (>mean + SD), 
fair (between mean + SD and mean − SD), and poor (<mean − SD) level. Effectiveness 
of CBIA-DM was assessed based on the increasing of participant number in good level 
which steady remains until 6 months post-intervention, time-required and cost/person 
for conducting CBIA-DM, and acceptance of CBIA-DM by the participants. RESULTS: 
In general quality of life, participant number of CBIA-DM (n = 30) increased from 
13.3% to 16.7%. In health status: general, physical, psychological, social-relation-
ships, and environment, increased from 23.3% to 40%, 13.3% to 23.3%, 16.7% to 
23.3%, 16.7% to 30%, and 16.7% to 26.7% respectively. Time-required for conduct-
ing CBIA-DM was one-third (3 vs. 9 hours) with cost/person 0.28 (US D 6.50 vs 
22.75) compared to DM-club. Participants expressed that CBIA-DM was enjoyable. 
CONCLUSIONS: CBIA-DM is cost effective strategy and has positive-impact on 
diabetic patients’ quality of life. 
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OBJECTIVES: To assess utilization and prescribing patterns of antidiabetics in 
Taiwan. METHODS: This cross-sectional study used the Taiwanese Diabetic Pay-for-
performance Register to extract a diabetic outpatient claim dataset from the National 
Health Insurance reimbursement data. Adult diabetic patients with at least one antidia-
betic prescription during 2004 to 2008 were indentiﬁ ed and prescription details were 
collected. Antidiabetic drugs were stratiﬁ ed by into injection (insulin) and ﬁ ve chemical 
groups of oral drugs. Pattern of antidiabetic combination was categorized by both type 
and number of combined drugs. Frequency of different prescribing pattern was calcu-
lated and presented as annual prescribing rate and analyzed by Cochran-Armitage trend 
test to test a signiﬁ cant ascending or descending trends. All data was processed in SAS 
9.1. 3. RESULTS: Over 95% prescribing patterns was composed of monotherapy, 
combination of any two, and combination of any three antidiabetics with approximate 
30%, 47%, and 18% annual prescription rate, respectively. The most frequent types 
of drugs within above three patterns included single sulfonylurea (SU1), combined one 
biguanide and one sulfonylurea (BG1+SU1), and combined one biguanide, one sulfo-
nylurea and one thiazolidinedione (BG1 + SU1 + TZD1). Prescribing rates of SU1 
(from 18.1% to 9.83%) and BG1 + SU1 (from 37.6% to 34.46%) decreased over the 
study period (P < 0.001), but BG1 + SU1 + TZD1 revealed an increasing trend (from 
8.45% to 10.99%, P < 0.001). Any prescribing pattern containing insulin presented 
an incremental annual prescribing rate, but the prescribing rates for those only con-
sisted of oral antidiabetics declined over time. CONCLUSIONS: Antidiabetic prescrib-
ing patterns in Taiwan have changed and shifted from simple monotherapy to multiple 
combinations of newer drugs. Meanwhile, prescribing rates of single-use or combine-
use insulin have also risen. It is necessary to further investigate the impacts of change 
prescription patterns on diabetic complications. 
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OBJECTIVES: Diabetes has become one of the major chronic diseases of the 21st 
century, and has ranked ﬁ fth on the main causes of death in Taiwan for years. The 
high cost of antidiabetic medications expenditure has brought the concern on 
the generic and brand drugs substitution. The purpose of the study was to investigate 
the effects of hospital drug brands changes on physicians’ prescription behavior and 
patients’ outcomes. METHODS: The study was conducted at a medical center in 
Taipei city. We recruited those who had taken the same medicine regularly from 
January 2004 to June 2004. In the next 4 years, the study hospital had changed the 
manufactures of metformin four times. Physicians’ prescription data and patients’ 
glycated hemoglobin values were collected. We retrospectively analyzed the prescrip-
tion patterns for oral antidiabetes medications of patients with persistence medication 
service in ﬁ ve different metformin brand stages. RESULTS: The results show 1) the 
average item of anti-diabetes drugs in each prescription was signiﬁ cantly increased; 2) 
the prescription rates were signiﬁ cant increased for acarbose and insulin, and decreased 
for metformin, glibenclamide and rosiglitazone; 3) The daily dose of metformin, which 
was on average between 1565 mg and 1611 mg, wasn’t increased signiﬁ cantly regard-
less of the change in manufacturers; and 4) The HbA1c values of study patients were 
increasing, but no signiﬁ cant difference was observed in different metformin brand 
stages. CONCLUSIONS: The use of generic drugs can effectively reduce the cost of 
medication. The results provide information for hospital administrators in drug pur-
chasing and price negotiating with the manufacturers. 
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OBJECTIVES: To study the transition time of patients with Type 2 diabetes mellitus 
(T2DM) progressing from “good” to “poor” glycemic control and its association with 
the number and type of diabetes-related vascular diseases such as coronary heart 
disease, stroke, eye complications, peripheral vascular disease, and nephropathy. 
METHODS: In this retrospective study, data from a disease registry were used. A 
cohort of T2DM patients who had attended either a hospital specialist clinic or a 
primary care diabetes service, and deemed to have “good” control (at least two 
consecutive HbA1c ≤ 7%) from October 2005 to March 2006 were included in this 
study. Patients were subsequently followed up for a period of 4 years. Time to “poor” 
glycemic control (HbA1c > 8%) for each diabetes-related vascular disease was calcu-
lated using Kaplan–Meier analysis. Hazards Ratio (HR) was adjusted for age, gender, 
ethnicity, BMI, duration of diabetes, baseline HbA1c, LDL-cholesterol and insulin use 
using Multivariate Cox analysis. RESULTS: There were 7739 T2DM patients, with 
median age of 68 years and baseline HbA1c of 6.4%. Over a quarter (28.9%) of 
patients reached “poor” control at the end of 4 years, with a median time of 575 days 
(95% CI: 550–600). Multivariate Cox regression analysis suggested that likelihood of 
“poor” control was increased with each additional diabetes-related vascular disease 
(AdjHR 1.14, 95% CI: 1.07–1.23) and higher for eye complications (AdjHR 1.47, 
95%CI: 1.17–1.86) and nephropathy (AdjHR 1.43, 95% CI:1.06–1.93). CONCLU-
SIONS: Despite starting with “good” glycemic control, 3 out of 10 T2DM patients 
progressed to “poor” glycemic control at the end of 4 years of study. Patients with 
more diabetes-related vascular diseases were at higher risk of progressing to “poor” 
control, particularly those with microvascular complications. 
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OBJECTIVES: Type 2 diabetes mellitus (T2DM) patients often have co-existing hyper-
tension and dyslipidemia and some develop retinopathy, peripheral vascular disease 
(PVD), stroke, nephropathy and coronary heart disease (CAD). This study investigates 
the prevalence of these conditions which are associated with T2DM and the associa-
tion with optimal glycemic control (HbA1c up to 7%). METHODS: This is a cross-
sectional study. We included all T2DM patients who were treated at the specialist 
outpatient clinics (SOCs) in three public-sector hospitals in Singapore during January 
2009 and were on follow-up at the same clinic for at least 12 months. All data were 
extracted from the National Healthcare Group (NHG) Diabetes Registry (CDMS), 
including the medical diagnosis and HbA1c result at the last visit. We compared the 
distribution of glycemic control for each diabetes-related condition and performed 
logistic regression for “optimal” glycemic control adjusting for age, gender and ethnic-
ity. RESULTS: Of the 3420 T2DM patients, 2919 (85%) with HbA1c results were 
analyzed. Mean age was 63.2 years, with 53% female and 66% Chinese, high preva-
lence of dyslipidemia (92.7%) and hypertension (74.5%). About 1249 (42.8%) 
patients had “optimal” glycemic control. CAD (28.7%) was the most common condi-
tion, followed by PVD (22.5%), retinopathy (21.8%), nephropathy (14.4%) and 
stroke (10.7%). The Malay group had the highest proportion of hypertension 
